Targeting of TP53-independent cell cycle checkpoints overcomes FOLFOX resistance in Metastatic Colorectal CancerCorina Behrenbruch(The Royal Melbourne Hospital), Frédéric Hollande(The University of Melbourne)bioRxiv (Cold Spring Harbor Laboratory)February 5, 202110.1101/2021.02.04.429849Cited by 6SaveCiteExport RISWatch citationsRelated PapersImpact of Tumor and Immunological Heterogeneity on the Anti-Cancer Immune Response|Cancers|2019|48